In case of suspected primary thrombocytosis, genetic testing accompanied by professional genetic counseling should address hallmarks of myeloid malignancies such as BCR-ABL1 and mutations associated with MPNs, that is JAK2, MPL, and CALR (for the respective mutations see Tables 2, 3, and 4). Here, JAK2 is linked to essential thrombocythemia.